CCT196969 T4133
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
CCT196969 is a novel orally available, pan-RAF inhibitor with anti-SRC activity. It also inhibits SRC, LCK, and the p38 MAPKs.
CAS nr:
1163719-56-9
Purity:
98%
Molecular Weight:
513,53
SMILES:
CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)cc2F)n(n1)-c1ccccc1
Formula:
C27H24FN7O3
Pathway:
MAPK,Tyrosine Kinase/Adaptors,Angiogenesis
Target:
Raf,Src,Src
